Tag Archives: UNLVF

Top Low Price Stocks To Own For 2018

The recent earning announcement on May 31, 2017 created sudden fear in the public’s mind and brought the stock price of Michael Kors (NYSE:KORS) down by around 9% in one day. As of this writing, the price remains at $33. In this article, I will discuss one negative and five positives, and explain why you should consider buying the stock at this low price.

One Negative

One negative, but a big one, that dragged down the stock price was the earning disappointment mainly driven by the macroeconomic situations in retail sector.

The entire retail sector has faced strong headwinds in recent years due to the emergence of online retailers (predominantly Amazon (NASDAQ:AMZN)), a strong dollar and a reduced number of tourists shopping in the U.S. The affected companies include Macy’s (NYSE:M), JCPenny (NYSE:JCP), Coach (NYSE:COH), Michael Kors, etc. The negative trends have driven down the stock price of the affected companies significantly in recent years, and the concern is legitimate in general,

Top Low Price Stocks To Own For 2018: Digital Ally Inc.(DGLY)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap police body cam stockDigital Ally, Inc (NASDAQ: DGLY) reported Q1 2017 earnings before the market opened today. Total Q1 revenue increased 19% to approximately $5.2 million primarily due to the large commercial order received in the first quarter 2017 from AMR for DVM-250 event recorders with FleetVU and asset tracking service. The AMR contract was for 1,550 DVM-250 systems as well as FleetVU manager cloud storage and system implementation, most of which were delivered in first quarter 2017 and had a positive impact on revenues. The net loss was $2,032,955 versus a net loss of $2,313,125.

  • [By Lisa Levin]

    Digital Ally, Inc. (NASDAQ: DGLY) was down, falling around 13 percent to $2.92. Digital Ally priced 1 million shares equity offering at $3 per share.

  • [By Peter Graham]

    Small cap police body cam stockDigital Ally, Inc (NASDAQ: DGLY) reportedQ3 2017 earnings after the market closed on Tuesday. Media generated police controversies have helpedpolice body cam players like Digital Ally,theclosest thing to a pure play police body cam stock. However, Digital Ally and body cam competitor Axon Enterprise (NASDAQ: AAXN), formerly known as TASER International, Inc (NASDAQ: TASR), have also been embroiled in messy patent infringement lawsuits.

  • [By Taylor Cox]

    Legal

    Axon Enterprise, Inc (NASDAQ: AAXN) and Digital Ally, Inc (NASDAQ: DGLY) to meet in court to discuss patent trial schedule
    AOL Instant Messenger to be decommissioned
    Friday

    Economic Data

  • [By Lisa Levin]

    Digital Ally, Inc. (NASDAQ: DGLY) shares shot up 35 percent to $4.25 after the company reported “significant victory” in its legal battle with Axon Enterprise Inc (NASDAQ: AAXN). The U.S. Patent and Trademark Office (PTO) denied Axon’s petition for inter partes review (IPR) of Digital Ally’s ‘452 patent, one of four IPRs Axon submitted in an attempt to invalidate Digital Ally’s lawsuit. Axon received a favorable PTO ruling on the ‘292 patent, the original point of dispute, in June.

Top Low Price Stocks To Own For 2018: Air Industries Group(AIRI)

Advisors’ Opinion:

  • [By Dividends4Life]

    Air Industries Group Inc. (AIRI), an aerospace and defense company, designs and manufactures structural parts and assemblies that focus on flight safety. Sept. 17, the company increased its quarterly dividend 100% to $0.125 per share. The dividend is is payable Oct. 15, 2013 to shareholders of record as of the close of business on Sept. 30, 2013. The yield based on the new payout is 6.9%.

Top Low Price Stocks To Own For 2018: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).

candlestick chart

Shares are down about 10% on Thursday after Twitter’s (NYSE:TWTR) as investors digest the company’s slowing revenue and user growth reported in its fourth quarter. But there were a few bright spots in the company’s earnings release as well. Here’s an overview of Twitter’s fourth-quarter performance.

The raw numbers

Metric

Q4 2016

Q4 2015

Change

Revenue

$717.2 million

$710.5 million

1%

Net loss per share

($0.23)

($0.13)

($0.10)

Non-GAAP net earnings per share

$0.16

candlestick chart: Power Solutions International, Inc.(PSIX)

Advisors’ Opinion:

  • [By Brent Slava]

    Power Solutions International Inc (NASDAQ: PSIX) shares plunged as much as 30 percent Tuesday on a report the company would be delisting from Nasdaq Inc (NASDAQ: NDAQ).

candlestick chart: Gentex Corporation(GNTX)

Advisors’ Opinion:

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.

candlestick chart: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Jack Foley]

    Up to now, I have been very vocal with respect to my bullish opinion regarding Gilead Sciences (NSDQ:GILD). Many investors and analysts alike have been trying to pick a bottom in the stock this year, but the stock stubbornly continues to trade below $75 a share. Worrying downward trends with respect to the company’s HCVdivision remain the dominant theme among investors. Gilead’s HCV division slipped by a whopping 31% last quarter, which resulted in HCV sales of $3.3 billion, which was well below expectation. The stock is now down almost 40% from its high back in June 2015. At present, investors simply can’t see a swift turnaround in the company’s quarterly sales. This has resulted in the company now trading with a price-to-earnings ratio of 6.94 which is ludicrously cheap for a company with a market cap of around $100billion. Nevertheless, the question still remains whether the stock is going lower.

  • [By Ben Levisohn]

    Shares of Gilead Sciences (GILD) have been under pressure ever since investors realized its hepatitis-C sales weren’t going to be able to keep growing. Since then, the market has been looking for Gilead to make an acquisition to kick start its growth again, while writing off its pipeline. Is that a mistake? It could be according to Jefferies analyst Brian Abrahams and team.

    Pixabay

    What are they seeing that others are missing? They explain:

    Based on an EASL title posted in recent weeks but we believe not broadly discussed, ACC inhibitor GS-0976 – one of GILD’s least-talked-about assets in NASH, in our opinion – appears to have demonstrated significant positive effects in the as-yet-unreported ph.II NASH study. The presentation title, “Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to suppression of hepatic de novo lipogenesis and significant improvements in MRI-PDFF, MRE, and markers of fibrosis after 12 weeks of therapy in patients with NASH,” indicates to us that recently-acquired ’0976′s novel mechanism, which has good scientific rationale, may likely be playing out…

    We believe this meaningfully de-risks a second NASH asset, and given add’l catalysts over the next 12mo could set the stage for increased recognition of potentially meaningful drivers w/in GILD’s internal pipeline. We see upside potential.

    I threw in the towel on Gilead in a column on Gilead earlier this month, when I argued that even an acquisition would not be enough to get it growing again.

    Shares of Gilead Sciences have dipped 0.1% to $68.97 at 1:05 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $296.51.

     

     

  • [By Keith Speights]

    There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck (NYSE:MRK). Here’s why these HIV drug stocks could be solid picks in 2017.

candlestick chart: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

candlestick chart: Coca-Cola Enterprises, Inc.(CCE)

Advisors’ Opinion:

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

candlestick chart: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).

Top 5 Gold Stocks To Watch For 2018

Tesla (TSLA) sold more 1.3 million shares of stock at $262 today–raising more than $350 million in the process–completing the capital raise announced on Wednesday.

Justin Sullivan/Getty Images

While the capital raise was no surprise, it was smaller than the market appeared to be expecting, even if today’s stock sale was a bit more than the 980,000 shares it initially said it would sell. That larger offering didn’t seem to bother anyone: Shares of Tesla have gained 0.7% to $263.81 at 9:32 a.m. this morning.

In a note today, Goldman Sachs analyst David Tamberrino kept his Sell rating on the stock intact, even as he raised his target price two bucks to $187 from $185. The reason? Tesla didn’t dilute shareholders as much as he had expected–hence the slightly higher target–but he still sees Tesla needing to raise cash again in 2018.

Top 5 Gold Stocks To Watch For 2018: Leading Brands Inc(LBIX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares dropped 13 percent to $1.99 following Q2 results. Leading Brands posted Q2 EBITDAS of $0.00 per share, compared to $0.09 per share during the same period last year.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares were also up, gaining 145 percent to $3.31 on no formal news from company. The stock rallied 215 percent over Tuesday and Wednesday of this week amid trader speculation stock could be sympathy play on move higher in Helios & Matheson. However, Leading Brands shares sold off 27 percent on Thursday.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares shot up 66 percent to $2.49 following Q1 results. Leading Brands reported Q1 earnings of $0.10 per share on revenue of $3.033 million.

Top 5 Gold Stocks To Watch For 2018: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

  • [By Matthew Briar]

    There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.

    It’s yet another reason for RTI investors to be enthused.

    Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.

    The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.

    The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.

    The company’

  • [By Matthew Briar]

    At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”

    It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.

    No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”

    Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho

  • [By Bryan Murphy]

    It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

    Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

    Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

    To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.

    Using its patented MAP process, Radient is able to selectiv

  • [By Matthew Briar]

    Although the past several years have been very good ones for the cannabis — marijuana and hemp — industry, it’s still mostly being done in an old, artisan-style fashion. Most companies haven’t figured out a way of scaling up their outputs by improving their operating/production efficiency, even though the market’s growth has merited. Radient Technologies Inc (CVE:RTI) represents that next evolution of the cannabinoid business, introducing a new approach to extracting cannabinoids from cannabis plants that will not only improve yields, but create a superior, purer product.

    Canada-based Radient Technologies has developed — and patented – an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along. To fully appreciate why it matters, however, one has look at the approach other ingredients suppliers are utilizing now.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated to 50 degrees Celsius (or more), and over the course of several hours, the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s hardly ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, a lot of things you don’t want to extract can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies’ microwave assisted processing changes all of this.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which

Top 5 Gold Stocks To Watch For 2018: Patheon Holdings Co枚peratief U.A. (PTHN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thermo Fisher Scientific Inc. (NYSE: TMO) announced plans to acquire Patheon NV (NYSE: PTHN) for $35 per share in cash.

    The deal is projected to complete by the end of 2017.

  • [By Jon C. Ogg]

    Patheon N.V. (NYSE: PTHN) was downgraded to Neutral from Outperform and the price target was cut to $28 from $34 (versus a $27.72 close, after an 11.7% drop) at Robert W. Baird. Patheon also was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

  • [By Benzinga News Desk]

    In the parched terrain just south of the United States border, the prices of food and other necessities follow the dollar, whose value has been climbing: Link

    ECONOMIC DATA
    Industrial Production (MoM) for Feb 0.00% vs 0.20% consensus estimate; Manufacturing Outputs (MoM) for Feb 0.50% vs 0.40% consensus estimate.
    The University of Michigan's consumer sentiment index for March is schedule for release at 10:00 a.m. ET.
    The index of leading economic indicators for February will be released at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    ANALYST RATINGS
    Wunderlich upgraded Adobe Systems (NASDAQ: ADBE) from Hold to Buy
    FBR Capital upgraded L Brands (NYSE: LB) from Market Perform to Outperform
    Morgan Stanley upgraded Dean Foods (NYSE: DF) from Neutral to Overweight
    Baird downgraded Patheon (NYSE: PTHN) from Outperform to Neutral
    Citigroup downgraded SeaWorld Entertainment Inc (NYSE: SEAS) from Neutral to Sell
    Goldman Sachs downgraded Macerich (NYSE: MAC) from Neutral to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Top 5 Gold Stocks To Watch For 2018: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Paul Ausick]

    ArQule Inc. (NASDAQ: ARQL) dropped about 23% Friday, to post a new 52-week low of $1.13 after closing at $1.47 on Thursday. The stock’s 52-week high is $2.17. Volume was about 15 times the daily average of around 150,000 shares. The biopharmaceutical company said this morning that a phase 3 trial of a cancer drug did not meet the primary endpoint of improving overall survival.

Top 5 Gold Stocks To Watch For 2018: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).